Phase II Study Using Thalidomide for the Treatment of ALS

This study has been completed.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT00140452
First received: August 31, 2005
Last updated: November 20, 2007
Last verified: November 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given